Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient

S. H. Tsai; T. Y. Chao; T. D. Chou; M. S. Dai

doi:10.1007/s00277-003-0667-4

Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient

S. H. Tsai, T. Y. Chao, T. D. Chou, M. S. Dai

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

Pyomyositis is a rare complication of chemotherapy. A 35-year-old male patient with myelodysplastic syndrome developed Stenotrophomonas maltophilia bacteremia shortly after chemotherapy, and Stenotrophomonas maltophilia-related pyomyositis was encountered after recovery from neutropenia. He recovered completely after surgical drainage and a protracted course of antibiotic treatment. It is postulated that subclinical myopathy, immunosuppression secondary to the malignancy, or chemotherapeutic drugs may predispose to pyomyositis. Early recognition of this unusual complication in a cancer patient undergoing chemotherapy can prevent further catastrophes.

Original language	English
Pages (from-to)	452-454
Number of pages	3
Journal	Annals of Hematology
Volume	82
Issue number	7
DOIs	https://doi.org/10.1007/s00277-003-0667-4
Publication status	Published - Jul 1 2003
Externally published	Yes

Keywords

Myelodysplastic syndrome
Pyomyositis
Stenotrophomonas maltophilia

ASJC Scopus subject areas

Hematology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00277-003-0667-4

Cite this

@article{e27e00a7cf6940b6adaab9379cc8f982,

title = "Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient",

abstract = "Pyomyositis is a rare complication of chemotherapy. A 35-year-old male patient with myelodysplastic syndrome developed Stenotrophomonas maltophilia bacteremia shortly after chemotherapy, and Stenotrophomonas maltophilia-related pyomyositis was encountered after recovery from neutropenia. He recovered completely after surgical drainage and a protracted course of antibiotic treatment. It is postulated that subclinical myopathy, immunosuppression secondary to the malignancy, or chemotherapeutic drugs may predispose to pyomyositis. Early recognition of this unusual complication in a cancer patient undergoing chemotherapy can prevent further catastrophes.",

keywords = "Myelodysplastic syndrome, Pyomyositis, Stenotrophomonas maltophilia",

author = "Tsai, {S. H.} and Chao, {T. Y.} and Chou, {T. D.} and Dai, {M. S.}",

year = "2003",

month = jul,

day = "1",

doi = "10.1007/s00277-003-0667-4",

language = "English",

volume = "82",

pages = "452--454",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "7",

}

TY - JOUR

T1 - Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient

AU - Tsai, S. H.

AU - Chao, T. Y.

AU - Chou, T. D.

AU - Dai, M. S.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Pyomyositis is a rare complication of chemotherapy. A 35-year-old male patient with myelodysplastic syndrome developed Stenotrophomonas maltophilia bacteremia shortly after chemotherapy, and Stenotrophomonas maltophilia-related pyomyositis was encountered after recovery from neutropenia. He recovered completely after surgical drainage and a protracted course of antibiotic treatment. It is postulated that subclinical myopathy, immunosuppression secondary to the malignancy, or chemotherapeutic drugs may predispose to pyomyositis. Early recognition of this unusual complication in a cancer patient undergoing chemotherapy can prevent further catastrophes.

AB - Pyomyositis is a rare complication of chemotherapy. A 35-year-old male patient with myelodysplastic syndrome developed Stenotrophomonas maltophilia bacteremia shortly after chemotherapy, and Stenotrophomonas maltophilia-related pyomyositis was encountered after recovery from neutropenia. He recovered completely after surgical drainage and a protracted course of antibiotic treatment. It is postulated that subclinical myopathy, immunosuppression secondary to the malignancy, or chemotherapeutic drugs may predispose to pyomyositis. Early recognition of this unusual complication in a cancer patient undergoing chemotherapy can prevent further catastrophes.

KW - Myelodysplastic syndrome

KW - Pyomyositis

KW - Stenotrophomonas maltophilia

UR - http://www.scopus.com/inward/record.url?scp=0043135143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043135143&partnerID=8YFLogxK

U2 - 10.1007/s00277-003-0667-4

DO - 10.1007/s00277-003-0667-4

M3 - Article

C2 - 12750843

AN - SCOPUS:0043135143

SN - 0939-5555

VL - 82

SP - 452

EP - 454

JO - Annals of Hematology

JF - Annals of Hematology

IS - 7

ER -

Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this